Compare MDXG & BOW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MDXG | BOW |
|---|---|---|
| Founded | 2006 | 2020 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 913.3M |
| IPO Year | N/A | 2024 |
| Metric | MDXG | BOW |
|---|---|---|
| Price | $7.32 | $27.75 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 6 |
| Target Price | $12.00 | ★ $36.17 |
| AVG Volume (30 Days) | ★ 774.9K | 180.5K |
| Earning Date | 10-29-2025 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 42.10 |
| EPS | 0.27 | ★ 1.53 |
| Revenue | $393,442,000.00 | ★ $519,241,000.00 |
| Revenue This Year | $19.13 | $16.05 |
| Revenue Next Year | $2.11 | $21.18 |
| P/E Ratio | $26.77 | ★ $18.17 |
| Revenue Growth | 14.77 | ★ 33.44 |
| 52 Week Low | $5.79 | $23.50 |
| 52 Week High | $9.71 | $42.29 |
| Indicator | MDXG | BOW |
|---|---|---|
| Relative Strength Index (RSI) | 57.66 | 57.42 |
| Support Level | $6.62 | $25.20 |
| Resistance Level | $7.30 | $28.17 |
| Average True Range (ATR) | 0.24 | 0.78 |
| MACD | 0.06 | 0.11 |
| Stochastic Oscillator | 91.33 | 82.42 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
Bowhead Specialty Holdings Inc offers commercial specialty property and casualty insurance products. The company offers underwriting solutions to various businesses across four underwriting divisions, which include Casualty, Professional Liability, Healthcare Liability, and Baleen Specialty. A majority of its revenue is generated from the Casualty division which specializes in general liability coverage, which protects a company against liability arising from bodily injury, personal injury or property damage, for risks in the construction, distribution, heavy manufacturing, real estate, public entity and hospitality segments and also considers underwriting risks in a broader range of industries. Geographically, the company operates in the United States.